D.E. Shaw & Co
QGENF

D.E. Shaw & Co’s QIAGEN NV QGENF Stock Holding History

D.E. Shaw & Co’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-729,597
Closed -$20.4M – 3836
2016
Q4 		$20.4M Buy
729,597
+390,877
+115% +$11M 0.03% 613
2016
Q3 		$9.3M Sell
338,720
-6,129
-2% -$168K 0.02% 930
2016
Q2 		$7.51M Sell
344,849
-507,370
-60% -$11.1M 0.01% 1054
2016
Q1 		$19M Buy
852,219
+792,753
+1,333% +$17.7M 0.03% 558
2015
Q4 		$1.63M Buy
59,466
+2,429
+4% +$66.7K ﹤0.01% 2288
2015
Q3 		$1.47M Sell
57,037
-36,936
-39% -$951K ﹤0.01% 2321
2015
Q2 		$2.31M Sell
93,973
-33,615
-26% -$827K ﹤0.01% 2074
2015
Q1 		$3.22M Sell
127,588
-89,761
-41% -$2.26M ﹤0.01% 1689
2014
Q4 		$5.09M Buy
217,349
+100,627
+86% +$2.36M 0.01% 1555
2014
Q3 		$2.66M Buy
+116,722
New +$2.66M ﹤0.01% 2016
2014
Q2 		– Sell
-86,930
Closed -$1.83M – 4918
2014
Q1 		$1.83M Buy
86,930
+37,528
+76% +$789K ﹤0.01% 2482
2013
Q4 		$1.15M Sell
49,402
-1,448
-3% -$33.7K ﹤0.01% 3040
2013
Q3 		$1.09M Buy
50,850
+37,480
+280% +$807K ﹤0.01% 2959
2013
Q2 		$263K Buy
+13,370
New +$263K ﹤0.01% 3644

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

D.E. Shaw & Co's QGENF Position: Q1 2017 in Review

D.E. Shaw & Co sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 729,597 shares — an estimated $20.4M sold.

D.E. Shaw & Co first reported a position in QGENF in Q2 2013 and held it in 14 quarters. The position peaked at $20.4M in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • D.E. Shaw & Co reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • D.E. Shaw & Co sold 729,597 QIAGEN NV shares in Q1 2017, an estimated $20.4M.
  • D.E. Shaw & Co first reported a position in QIAGEN NV in Q2 2013 and held it in 14 quarters.
  • D.E. Shaw & Co's QIAGEN NV position peaked at $20.4M in Q4 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on D.E. Shaw & Co's 13F filing for Q1 2017, filed 15 May 2017.